Clinical trial

Testosterone and Its Metabolites in GID

NCT00146146 · Unita Complessa di Ostetricia e Ginecologia, Other · Completed

Key facts

NCT number NCT00146146
Title Testosterone and Its Metabolites in GID
Official title Role of Testosterone and Its Metabolites Regarding Different Physiological Functions in Subjects Affected by Gender Identity Disorder (FtM Transsexuals)
Lead sponsor Unita Complessa di Ostetricia e Ginecologia, Other
Collaborators Schering-Plough Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Transsexualism
Intervention type Drug
Interventions testosterone undecanoate alone, testosterone undecanoate plus letrozole, testosterone undecanoate plus dutasteride
Enrollment 15
Start date May 1, 2005
Primary completion May 1, 2006
Completion Jan 1, 2008
First posted Sep 5, 2005
Last update posted Mar 21, 2018
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies